H2-antagonist in IgE-mediated type I hypersensitivity reactions: what literature says so far?
- PMID: 33849573
- PMCID: PMC8042967
- DOI: 10.1186/s12948-021-00143-y
H2-antagonist in IgE-mediated type I hypersensitivity reactions: what literature says so far?
Abstract
Histamine is a monoamine synthesized from the amino acid histidine that is well-known for its role in IgE-mediated anaphylaxis but has shown pleiotropic effects on the immune system, especially in order to promote inflammatory responses. H1-receptor antagonist are common drugs used in mild/moderate allergic reactions whereas H2-receptor antagonist are commonly administered in gastric ulcer but showed some properties in allergy too. The EAACI guidelines for diagnosis and treatment of anaphylactic reactions recommend their use as third-line therapy in adjunct to H1-antagonists. The purpose of this article is to produce a complete summary of findings and evidence known so far about the usefulness of H2-receptor antagonist in allergic reactons.
Keywords: Allergy; H2-receptor antagonist; Histamine; Type-I hypersensitivity reaction.
Conflict of interest statement
The authors declare that they have no competing interests.
References
-
- Baumer W, Rossbach K. [Histamine as an immunomodulator] J Dtsch Dermatol Ges. 2010;8(7):495–504. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
